Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 11/20 | 0.50 |
| ▸ | PARP1 | P09874 | 6/20 | 0.49 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.35 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.35 |
| ▸ | JAK2 | O60674 | 1/20 | 0.35 |
| ▸ | AKT1 | P31749 | 1/20 | 0.34 |
| ▸ | AKT2 | P31751 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17971373 | 0.87 | TNKS (0.47) | TNKSPARP1CHEK1 | |
| SCHEMBL16578900 | 0.84 | TNKS (0.54) | TNKSPARP1CHEK1CNR2 | |
| SCHEMBL18699319 | 0.80 | TNKS (0.55) | TNKSPARP1CHEK1CNR2 | |
| SCHEMBL16578741 | 0.80 | TNKS (0.76) | TNKSPARP1CHEK1AKT1AKT2 | |
| SCHEMBL16569744 | 0.79 | TNKS (0.72) | TNKSPARP1CHEK1 | |
| SCHEMBL19882216 | 0.78 | TNKS (0.68) | TNKSPARP1CHEK1JAK2 | |
| SCHEMBL17971369 | 0.78 | TNKS (0.68) | TNKSPARP1CHEK1JAK2 | |
| SCHEMBL16569773 | 0.78 | TNKS (0.74) | TNKSPARP1 | |
| SCHEMBL18699318 | 0.77 | TNKS (0.56) | TNKSPARP1CHEK1AKT1AKT2 | |
| SCHEMBL16569747 | 0.77 | TNKS (0.49) | TNKSPARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015036759-A1 | 3-ARYL-5-SUBSTITUTED-ISOQUINOLIN-1-ONE COMPOUNDS AND THEIR THERAPEUTIC USE | INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) (GB) | 2015-03-19 | — | — | WO | disclosed |